UNSPSC 51172125: Drofenine or drofenine hydrochloride

This classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formulas C20H31NO2 and C20H31NO2.ClH, preparations that US FDA regulates as active ingredients or moieties under Unique Ingredient Identifiers 4QWV355536 and MVB31OPW05, the base compound being chemically known as cyclohexaneacetic acid, .alpha.-phenyl-, 2- (diethylamino)ethyl ester but generally known as drofenine, which bears US NIH Compound Identifier 3166.

UNSPSC 51172125 Drofenine or drofenine hydrochloride is a Commodity code under which state and local governments procure drug testing services and related laboratory operations for offender supervision and community corrections programs. The recent solicitation activity does not reflect direct procurement of the pharmaceutical product itself; rather, the code appears to capture testing services that may employ drofenine-based assays or screening methodologies as part of broader specimen collection and confirmatory testing workflows. Collin County Community Supervision and Corrections Department's RFP 2026-327 exemplifies the scope: the county is soliciting offender specimen collection and drug testing services including staffing at collection sites, immunoassay screening with LC/MS/MS or GC/MS confirmation, electronic result reporting, and alternative testing methodologies such as oral fluid and hair testing. The issuing body is a county-level community corrections department operating under state criminal justice appropriations, a profile typical for this code among state and local buyers. The estimated contract value is $600,000 over a two-year term with three optional one-year renewals.

Collin County, Texas represents the only recent state-local opportunity identified under this code. The RFP 2026-327 closed on July 23, 2026 (posted September 25, 2026, indicating a posting date after the nominal deadline). The county seeks annual testing capacity of approximately 25,031 tests across five-panel and six-panel screens with ancillary testing, delivered at two sites in Plano and McKinney during standard business hours plus five Saturdays annually. The successful vendor must hold SAMHSA, Texas DPS, or CAP lab certification and submit pricing on a per-test basis across three service models: screening only, confirmation after screening, and screening with automatic confirmation of positives. Award is expected August 10, 2026, and the county reserves the right to split the award among multiple vendors. The sparse recent-activity block suggests limited state-local procurement velocity under this specific code; the single Texas opportunity may not represent a broader or recurring category of buying.